Coronavirus (COVID-19)

This page contains medical information for clinicians on the 2019 Novel Coronavirus (COVID-19, also called 2019-nCoV, and now clinically SARS‐CoV‐2). This section includes articles that pertain to clinicians and cardiologists on the virus, new technologies being deployed to fight the virus and clinical information from various sources. Here are direct links for medical professionals to COVID-19 resources from the U.S. Food and Drug Administration (FDA)Centers for Disease Control (CDC) and the World Health Organization (WHO). Daily world-wide statistics on the coronavirus outbreak are available from the WHO Situations Reports. Here is the Centers for Medicare and Medicaid Services (CMS) frequently asked questions and answers (FAQs) for healthcare providers regarding Medicare payment for laboratory tests and other services related to the COVID-19.

ESC Congress Goes Virtual Amid COVID-19 Concerns. #ESC #ESCcongress
News | ESC | May 06, 2020
May 6, 2020 — The European Society of Cardiology (ESC), one of the world's largest cardiovascular conferences, is...
EuroPCR Cancels Annual Meeting Due to COVID-19. #SARScov2 #COVID19
News | EuroPCR | May 05, 2020
May 5, 2020 — The large European interventional cardiology conference EuroPCR has been cancelled due to the contenting...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Chest CT findings of pediatric patients with COVID-19 on transaxial images. (a) Male, 2 months old, 2 days after symptom onset. Patchy ground-glass opacities GGO in the right lower lobe

Chest CT findings of pediatric patients with COVID-19 on transaxial images. Male, 2 months old, 2 days after symptom onset. Patchy ground-glass opacities GGO in the right lower lobe. Image courtesy of Radiology: Cardiothoracic Imaging

News | Coronavirus (COVID-19) | May 05, 2020
May 5, 2020 — Children and teenagers with COVID-19 showed distinctive clinical and computed tomography (CT) findings,...
FDA Grants Emergency Use Authorization to VitalConnect for Cardiac Monitoring in COVID-19 Patients. SARS-CoV-2 QT monitoring. #COVID19
News | May 05, 2020
May 5, 2020 — Wearable biosensor vendor VitalConnect Inc. was granted emergency use authorization (EUA) status by the U...
SCCT Plans to Make 2020 Annual Meeting Virtual Due to COVID-19. #SCCT2020 #SCCT20 #CCTfirst
News | CT Angiography (CTA) | May 05, 2020
May 5, 2020 — The Society of Cardiovascular Computed Tomography (SCCT) announced plans  this week to hold its annual...
Bilateral pulmonary embolisms seen on spectral CT. Photo courtesy of Siemens Healthineers.

Bilateral pulmonary embolisms seen on spectral CT. Photo courtesy of Siemens Healthineers.

Feature | Coronavirus (COVID-19) | May 04, 2020
May 4, 2020 — A committee comprised of vascular surgeons, medical physicians and technologists from the University of...
Cardiac Insight's Heart@Home ECG Test Kit can help address new telehealth demands placed on cardiology practices by the COVID-19 response using arrhythmia diagnosis technology of the wearable Cardea Solo Sensor.

Cardiac Insight's [email protected] ECG Test Kit can help address new telehealth demands placed on cardiology practices by the COVID-19 response using arrhythmia diagnosis technology of the wearable Cardea Solo Sensor. 

News | ECG Wireless Remote Access | May 04, 2020
May 4, 2020 — Cardiac Insight Inc., a U.S.-based digital healthcare innovator specializing in body-worn sensor...
Videos | Coronavirus (COVID-19) | May 01, 2020
Thomas Maddox, M.D., MSc, FACC, the chair of the American College of Cardiology (ACC) Science and Quality Committee,...
EP lab photo from Philips Healthcare
News | EP Lab | April 30, 2020
May 1, 2020 — The Heart Rhythm Society (HRS) has created a COVID-19 Task Force to make recommendations related to...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Pulmonary CT angiography of a 68 year old male. The CT scan was obtained 10 days after the onset of COVID-19 symptoms and on the day the patient was transferred to the intensive care unit.

Figure 2: Pulmonary CT angiography of a 68 year old male. The CT scan was obtained 10 days after the onset of COVID-19 symptoms and on the day the patient was transferred to the intensive care unit. Axial CT images (lung windows) (a,b) show peripheral ground-glass opacities (arrow) associated with areas of consolidation in dependent portions of the lung (arrowheads). Interlobular reticulations, bronchiectasis (black arrow) and lung architectural distortion are present. Involvement of the lung volume was estimated to be between 25% and 50%. Coronal CT reformations (mediastinum windows) (c,d) show bilateral lobar and segmental pulmonary embolism (black arrows). Courtesy of RSNA

News | Coronavirus (COVID-19) | April 30, 2020
April 23, 2020 — A special report published in the journal Radiology outlines prevention, diagnosis and treatment of...
There have been several safety reports to the FDA that COVID-19 patients receiving hydroxychloroquine and chloroquine, either aloneaths and Injuries From Use of Antimalarial Drugs in COVID-19 Patients. he U.S. Food and Drug Administration (FDA) issued a Drug Safety Communication today reminding doctors there are serious side effects when using hydroxychloroquine and chloroquine in the off-lable use to treat COVID-19 patients. This includes potentially life-threatening heart rhythms. #COVID19 #SARScov2

There have been several safety reports to the FDA that COVID-19 patients receiving hydroxychloroquine and chloroquine, either alone or combined with azithromycin or other QT prolonging medicines, have caused serious These adverse events, including death. Events reported included QT interval prolongation, ventricular tachycardia and ventricular fibrillation.

Feature | Coronavirus (COVID-19) | April 24, 2020 | Dave Fornell, Editor
April 23, 2020 — The U.S. Food and Drug Administration (FDA) issued a Drug Safety Communication today reminding doctors...
LivaNova Modifies its ECMO Indications Beyond Six Hours to Address COVID-19. The FDA expanded the use indications for ECMO systems April 6 so tthey can be used beyond six hours and for use in COVID-19 patients in need of circulatory and pulmonary support.

The FDA expanded the use indications for ECMO systems April 6 so the systems can be used beyond six hours and for use in COVID-19 patients in need of circulatory and pulmonary support. Image shows an ECMO team at work at Tufts Medical Center in Boston in December 2019. Photo by Dave Fornell

News | Coronavirus (COVID-19) | April 23, 2020
April 23, 2020 – LivaNova PLC said the U.S. Food and Drug Administration (FDA) is now permitting the company to expand...
Videos | Coronavirus (COVID-19) | April 22, 2020
Ehtisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiography and Interventions (SCAI) and...
SCAI, ACC and ACEP release consensus document on how to manage acute myocardial infarctions during the SARS-C0V-2 outbreak, #COVIF19 #coronavirus
Feature | Cath Lab | April 22, 2020
April 22, 2020 — The Society for Cardiovascular Angiography and Interventions (SCAI), along with the American College...
Videos | Coronavirus (COVID-19) | April 22, 2020
Justin Fried, M.D., Attending cardiologist at Columbia University Irving Medical Center, New York City, and assistant...